|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
US6923175B2
(en)
|
2002-03-20 |
2005-08-02 |
Mannkind Corporation |
Inhalation apparatus
|
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
|
KR20130066695A
(ko)
|
2004-08-23 |
2013-06-20 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
|
WO2006111169A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
|
MX373000B
(es)
|
2005-09-14 |
2020-05-21 |
Mannkind Corp |
Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
|
|
US20070148140A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Zoltan Laboratories Llc |
Compositions and methods to enhance viability and function of islet cells
|
|
EP1986679B1
(en)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
|
TW200843794A
(en)
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
|
WO2008092209A1
(en)
*
|
2007-02-01 |
2008-08-07 |
Arana Therapeutics Limited |
Protein construct with improved properties
|
|
CN101827626B
(zh)
|
2008-06-13 |
2015-03-18 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
ES2421385T3
(es)
|
2008-06-20 |
2013-09-02 |
Mannkind Corp |
Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
|
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
MX2011003277A
(es)
*
|
2008-10-14 |
2012-09-21 |
Salubrious Pharmaceuticals LLC |
Proceso para el tratamiento de la artritis reumatoide, temblores/enfermedad de parkinson, esclerosis multiple y cancer de tipo no viral.
|
|
CN102256618A
(zh)
|
2008-10-17 |
2011-11-23 |
赛诺菲-安万特德国有限公司 |
胰岛素和glp-1激动剂的组合
|
|
US8748377B2
(en)
|
2008-12-10 |
2014-06-10 |
Glaxosmithkline Llc |
Pharmaceutical compositions
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
DK2405963T3
(da)
|
2009-03-11 |
2013-12-16 |
Mannkind Corp |
Apparat, system og fremgangsmåde til at måle modstand i en inhalator
|
|
KR102584844B1
(ko)
|
2009-06-12 |
2023-10-04 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
|
PL2451437T3
(pl)
|
2009-07-06 |
2017-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Wodne preparaty insuliny zawierające metioninę
|
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
|
NZ599847A
(en)
|
2009-11-13 |
2013-09-27 |
Sanofi Aventis Deutschland |
Pharmaceutical composition comprising a glp-1 agonist and methionine
|
|
TR201809460T4
(tr)
|
2009-11-13 |
2018-07-23 |
Sanofi Aventis Deutschland |
Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
|
|
JP2013525491A
(ja)
|
2010-05-04 |
2013-06-20 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
心血管障害を治療または予防し心血管保護を提供する方法
|
|
CA2797095A1
(en)
|
2010-05-13 |
2011-11-17 |
Indiana University Research And Technology Corporation |
Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
|
|
AU2011202239C1
(en)
|
2010-05-19 |
2017-03-16 |
Sanofi |
Long-acting formulations of insulins
|
|
CN102985125A
(zh)
|
2010-06-21 |
2013-03-20 |
曼金德公司 |
干粉药物输送系统和方法
|
|
RU2580317C2
(ru)
|
2010-06-24 |
2016-04-10 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Пептидные пролекарства, принадлежащие к суперсемейству амид-содержащих глюкагонов
|
|
WO2012028172A1
(en)
|
2010-08-30 |
2012-03-08 |
Sanofi-Aventis Deutschland Gmbh |
Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
|
|
US20140045754A1
(en)
*
|
2011-01-19 |
2014-02-13 |
Joern Drustrup |
Glp-1 compositions
|
|
SG194034A1
(en)
|
2011-04-01 |
2013-11-29 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
US9950038B2
(en)
*
|
2011-08-05 |
2018-04-24 |
The Trustees Of The Universiy Of Pennsylvania |
Methods and compositions for inhibiting delayed graft function
|
|
AR087693A1
(es)
|
2011-08-29 |
2014-04-09 |
Sanofi Aventis Deutschland |
Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
|
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
|
MX2014004983A
(es)
|
2011-10-24 |
2014-09-22 |
Mannkid Corp |
Metodos y composiciones para tratar dolor.
|
|
RU2014117678A
(ru)
|
2011-11-17 |
2015-12-27 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Пептиды глюкагонового суперсемейства, обладающие глюкокортикоидной рецепторной активностью
|
|
CA2864655A1
(en)
*
|
2012-03-01 |
2013-09-06 |
Yeda Research And Development Co. Ltd. |
Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
|
|
KR102264177B1
(ko)
|
2012-07-12 |
2021-06-11 |
맨카인드 코포레이션 |
건조 분말 약물 전달 시스템 및 방법
|
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
|
EP3587404B1
(en)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
|
|
EP2983697B1
(en)
|
2013-04-03 |
2018-10-31 |
Sanofi |
Treatment of diabetes mellitus by long acting formulations of insulins
|
|
MX375448B
(es)
|
2013-07-18 |
2025-03-06 |
Mannkind Corp |
Composiciones farmacéuticas en polvo seco estables al calor y métodos.
|
|
EP3030294B1
(en)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflation apparatus
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
PE20171622A1
(es)
|
2014-12-12 |
2017-11-02 |
Sanofi Aventis Deutschland |
Formulacion de relacion fija de insulina glargina/lixisenatida
|
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第２型糖尿病病患治療
|
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第２型糖尿病病患之治療
|
|
EP3289074B1
(en)
*
|
2015-04-28 |
2023-10-04 |
Université de Strasbourg |
Clinical gene signature-based human cell culture model and uses thereof
|
|
CN105504026B
(zh)
*
|
2015-12-24 |
2018-12-07 |
广东医科大学 |
一种pac1-r和glp-1r的双向激动剂ot23及应用
|
|
WO2017211321A1
(zh)
*
|
2016-06-08 |
2017-12-14 |
上海交通大学医学院 |
增强激动型抗体活性的抗体重链恒定区序列
|
|
TWI829687B
(zh)
|
2018-05-07 |
2024-01-21 |
丹麥商諾佛 儂迪克股份有限公司 |
包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
|
|
CN115697414A
(zh)
|
2020-06-03 |
2023-02-03 |
哥本哈根大学 |
Glp1r激动剂nmdar拮抗剂缀合物
|